Escaping the atherogenic trap: Preventing LDL fusion and binding in the intima

Mast cell secretory granules: armed for battle

Wernersson, S., & Pejler, G. (2014) · Nature reviews. Immunology · doi:10.1038/nri3690 · Cited by 968 · see citing works

Mechanisms of foam cell formation in atherosclerosis

Chistiakov, D. A., Melnichenko, A. А., Myasoedova, V. A., Grechko, A. V., & Orekhov, A. N. (2017) · Journal of Molecular Medicine · doi:10.1007/s00109-017-1575-8 · Cited by 748 · see citing works

An abundant dysfunctional apolipoprotein A1 in human atheroma

Huang, Y. R., DiDonato, J. A., Levison, B. S., Schmitt, D., Li, L., Wu, Y., Buffa, J. A., Kim, T., Gerstenecker, G. S., Gu, X., et al. (2014) · Nature Medicine · doi:10.1038/nm.3459 · Cited by 363 · see citing works

Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice

Martel, C., Li, W., Fulp, B. E., Platt, A. M., Gautier, E. L., Westerterp, M., Bittman, R., Tall, A. R., Chen, S., Thomas, M. J., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci63685 · Cited by 332 · see citing works

Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

Tardif, J.-C., Ballantyne, C. M., Barter, P., Dasseux, J.-L., Fayad, Z. A., Guertin, M.-C., Kastelein, J. J. P., Keyserling, C., Klepp, H., Koenig, W., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu171 · Cited by 251 · see citing works

Macrophage Sortilin Promotes LDL Uptake, Foam Cell Formation, and Atherosclerosis

Patel, K. M., Strong, A., Tohyama, J., Jin, X., Morales, C. R., Billheimer, J. T., Millar, J. S., Kruth, H. S., & Rader, D. J. (2015) · Circulation Research · doi:10.1161/circresaha.116.305811 · Cited by 190 · see citing works

Peritoneal Cell-Derived Mast Cells: An In Vitro Model of Mature Serosal-Type Mouse Mast Cells

Malbec, O., Roget, K., Schiffer, C., Iannascoli, B., Dumas, A. R., Arock, M., & Daëron, M. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.10.6465 · Cited by 157 · see citing works

Mast cell proteases as pharmacological targets

Caughey, G. H. (2015) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2015.04.045 · Cited by 151 · see citing works

Effects of native and myeloperoxidase-modified apolipoprotein A-I on reverse cholesterol transport and atherosclerosis in mice

Hewing, B., Parathath, S., Barrett, T. J., Chung, W. K. K., Astudillo, Y., Hamada, T., Ramkhelawon, B., Tallant, T. C., Yusufishaq, M., DiDonato, J., et al. (2014) · Arteriosclerosis, Thrombosis and Vascular Biology · doi:10.1161/atvbaha.113.303044 · Cited by 147 · see citing works

Cathepsin G: Roles in antigen presentation and beyond

Burster, T., Macmillan, H., Hou, T., Boehm, B. O., & Mellins, E. (2009) · Molecular Immunology · doi:10.1016/j.molimm.2009.10.003 · Cited by 106 · see citing works

Proteolytic Enzymes of Mast Cell Granules Degrade Low Density Lipoproteins and Promote Their Granule-mediated Uptake by Macrophages in Vitro

Kokkonen, J. O., & Kovanen, P. T. (1989) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)81685-4 · Cited by 83 · see citing works

Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein

Chellan, B., Reardon, C. A., Getz, G. S., & Bowman, M. A. H. (2016) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.116.307306 · Cited by 76 · see citing works

Mast cell chymase inhibition reduces atherosclerotic plaque progression and improves plaque stability in ApoE−/− mice

Bot, I., Bot, M., van Heiningen, S. H., van Santbrink, P. J., Lankhuizen, I. M., HARTMAN, P. G., Gruener, S., Hilpert, H., van Berkel, T. J. C., Fingerle, J., et al. (2010) · Cardiovascular Research · doi:10.1093/cvr/cvq260 · Cited by 69 · see citing works

Novel Apo E-Derived ABCA1 Agonist Peptide (CS-6253) Promotes Reverse Cholesterol Transport and Induces Formation of preβ-1 HDL In Vitro

Hafiane, A., Bielicki, J. K., Johansson, J. O., & Genest, J. J. (2015) · PLoS ONE · doi:10.1371/journal.pone.0131997 · Cited by 61 · see citing works

Cathepsin G activity lowers plasma LDL and reduces atherosclerosis

Wang, J., Sjöberg, S., Tang, T., Öörni, K., Wu, W., Liu, C., Secco, B., Tia, V., Sukhova, G. K., Fernandes, C. R., et al. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.07.026 · Cited by 47 · see citing works

Recent clinical trials evaluating benefit of drug therapy for modification of HDL cholesterol

Wright, R. S. (2013) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e328362059d · Cited by 37 · see citing works

Proteolysis sensitizes LDL particles to phospholipolysis by secretory phospholipase A2 group V and secretory sphingomyelinase

Plihtari, R., Hurt‐Camejo, E., Öörni, K., & Kovanen, P. T. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003103 · Cited by 25 · see citing works

Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human Cathepsin G

Sissi, C., Lucatello, L., Naggi, A., Torri, G., & Palumbo, M. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.10.027 · Cited by 19 · see citing works

Endothelin receptor antagonist macitentan or deletion of mouse mast cell protease 4 delays lesion development in atherosclerotic mice

Houde, M., Desbiens, L., Schwertani, A. G., Pejler, G., Iglarz, M., & D’Orléans-Juste, P. (2016) · Life Sciences · doi:10.1016/j.lfs.2016.03.018 · Cited by 11 · see citing works

Comparative effectiveness of lipid-lowering treatments to reduce cardiovascular disease

Suh, D., Griggs, S. K., Henderson, E. R., Lee, S.-M., & Park, T. (2017) · Expert Review of Pharmacoeconomics & Outcomes Research · doi:10.1080/14737167.2018.1407246 · Cited by 11 · see citing works

Inflammation and its resolution in atherosclerosis: mediators and therapeutic opportunities

Bäck, M., Yurdagul, A., Tabas, I., Öörni, K., & Kovanen, P. T. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0169-2 · Cited by 1,341 · see citing works

Immunobiology of Atherosclerosis: A Complex Net of Interactions

Herrero‐Fernández, B., Gómez-Bris, R., Somovilla-Crespo, B., & González, J. M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215293 · Cited by 152 · see citing works

Caspase-11-Gasdermin D-Mediated Pyroptosis Is Involved in the Pathogenesis of Atherosclerosis

Jiang, M., Sun, X., Liu, S., Tang, Y. J., Shi, Y., Bai, Y., Wang, Y., Yang, Q., Yang, Q., Jiang, W., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.657486 · Cited by 72 · see citing works

Impact of dietary n-6/n-3 fatty acid ratio of atherosclerosis risk: A review

Cao, M., Yang, F., McClements, D. J., Guo, Y., Liu, R., Chang, M., Wei, W., Jin, J., & Wang, X. (2024) · Progress in Lipid Research · doi:10.1016/j.plipres.2024.101289 · Cited by 37 · see citing works

Apolipoprotein B/AI ratio as an independent risk factor for intracranial atherosclerotic stenosis

Sun, Y., Hou, X., Wang, D., Ma, Y., Tan, C., Sun, F.-R., Cui, M., Dong, Q., Tan, L., & Yu, J. (2019) · Aging · doi:10.18632/aging.102216 · Cited by 14 · see citing works

Imaging and Targeting Coronary Artery Inflammation

West, H. W., & Antoniades, C. A. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8128 · Cited by 10 · see citing works

Inflammation and Epicardial Adipose Tissue in the Pathobiology of Atherogenesis and Neointimal Hyperplasia Following Coronary Intervention

Thankam, F. G., Radwan, M. M., & Agrawal, D. K. (2020) · Springer eBooks · doi:10.1007/978-3-030-47336-5_13 · Cited by 1 · see citing works

Rôle de la phosphatase alcaline non spécifique du tissu "TNAP" dans la calcification des plaques d’athérosclérose

Kawtharany, L. (2022) · theses.fr (ABES) · doi:10.70675/8266a539zd176z4839zb688z6235f93ffe7c

New Hope for Lipid-Lowering Beyond Statins: Effect of IMPROVE-IT on Understanding and Implementation of Atherosclerosis Prevention

Anderson, T. J. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.03.019 · Cited by 8 · see citing works

The Role of Statins in ASCVD

Lu, C., Lu, F. Y., Zhu, Y., Zheng, L., & Liu, D. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1001350

Drugs for Treatment of Dyslipidemias

Seifert, R. (2019) · Springer eBooks · doi:10.1007/978-3-030-18899-3_22

Reduction of LDL-C by more than 60% with the HMG-CoA reductase inhibitor atorvastatin

Nawrocki, J. W., Weiss, S., Sprecher, D. L., Davidson, M., Schwartz, S., Lupien, P. J., Jones, P. J. H., Haber, H. E., & Black, D. M. (1994) · Atherosclerosis · doi:10.1016/0021-9150(94)94255-2

Lowering low-density lipoprotein cholesterol: from mechanisms to therapies

Luo, J., Wang, J.-K., & Song, B. (2022) · Life Metabolism · doi:10.1093/lifemeta/loac004 · Cited by 37 · see citing works